medtech

R&D

Tariff turbulence: Navigating US trade shifts in the medtech...

The US has been at the centre of a shift in global trade dynamics these last few weeks, resulting from a rise in geopolitical and economic uncertainty.

News

Antoine Papiernik, chairman and managing partner at Sofinnova Partners

Sofinnova raises €1.2bn to back 'up to 60' companies

Sofinnova has raised €1.2bn that it says could support 50 to 60 companies across biotech, medtech, industrial biotech, and digital medicine.

Sales & Marketing

Unlocking impact and growth at times of demerger

Pharma and medtech companies have undergone unprecedented growth through aggressive M&A over the

Sales & Marketing

Solution Spotlight: Aktiia Blood Pressure Technology

The Aktiia Medical Grade Wearable is a clinically validated device designed to provide accurate blood pressure measurements passively, regardless of whether the user is sitting, lying, or s

R&D

LSX World Congress – Day Two

On Day Two of 2024's LSX World Congress, we’ll hear about the biotech/biopharma IPO market, the 2024 US Presidential election, and about the future of digital health.

R&D